Nanotechnology-Based Targeting of mTOR Signaling in Cancer
Mee-Sup Yoon Department of Molecular Medicine, School of Medicine, Lee Gil Ya Cancer and Diabetes Institute, Department of Health Sciences and Technology, GAIHST, Gachon University, Incheon 21999, Republic of KoreaCorrespondence: Mee-Sup Yoon Tel +82-32-899-6067Fax +82-32-899-6039Email msyoon@gachon...
Enregistré dans:
Auteur principal: | Yoon MS |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2020
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/d2a6893fdadb4cce8f8efde3d73d48de |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Blocking mammalian target of rapamycin (mTOR) improves neuropathic pain evoked by spinal cord injury
par: Wang Xiaoping, et autres
Publié: (2016) -
Cerebral mTOR signal and pro-inflammatory cytokines in Alzheimer’s disease rats
par: Wang Xu, et autres
Publié: (2016) -
Dual Targeting by Inhibition of Phosphoinositide-3-Kinase and Mammalian Target of Rapamycin Attenuates the Neuroinflammatory Responses in Murine Hippocampal Cells and Seizures in C57BL/6 Mice
par: Preeti Vyas, et autres
Publié: (2021) -
Rapamycin attenuates PLA2R activation-mediated podocyte apoptosis via the PI3K/AKT/mTOR pathway
par: Terry Ting-Yu Chiou, et autres
Publié: (2021) -
Clinical Evaluation of Everolimus in the Treatment of Neuroendocrine Tumors of the Lung: Patient Selection and Special Considerations. A Systematic and Critical Review of the Literature
par: Peri M, et autres
Publié: (2020)